Table 2.
Characteristics' comparison between non-appropriate and appropriate prescriptions
| Non-appropriate prescription (n = 122) n (%) |
Appropriate prescription (n = 188) n (%) |
p value | |
|---|---|---|---|
| Male Sex | 55 (45.1) | 94 (50) | 0.397 |
| Age --Mean (SD) | 65.22 (20.9) | 66.85 (20.6) | 0.501 |
| Diagnosis | 0.020 | ||
| Infections | 49 (40.2) | 75 (39.9) | |
| Neurological disorders | 19 (15.6) | 21 (11.2) | |
| Gastrointestinal diseases | 5 (4.1) | 26 (13.8) | |
| Electrolyte disturbances | 9 (7.4) | 16 (8.5) | |
| Cancer/Chemotherapy | 7 (5.7) | 12 (6.4) | |
| Respiratory diseases | 6 (4.9) | 10 (5.3) | |
| Cardiac diseases | 9 (7.4) | 2 (1.1) | |
| Others | 18 (14.8) | 26 (13) | |
| Contraindications for pharmacologic prophylaxis | 15 (12.3) | 39 (20.7) | 0.055 |
| Surgery | 24 (19.7) | 14 (7.4) | 0.001 |
| Prophylaxis prescription upon admission | 96 (78.7) | 163 (88.2) | 0.024 |
| Obesity | 12 (9.8) | 9 (4.8) | 0.084 |
| Renal failure | 21 (17.2) | 29 (15.5) | 0.676 |
| Prophylaxis discontinuation during hospitalization | 18 (14.8) | 16 (8.5) | 0.086 |
| Stay at ICU during hospitalization | 31 (25.4) | 39 (20.7) | 0.337 |
| Study enrollment | 0.020 | ||
| First half | 71 (58.2) | 84 (44.7) | |
| Second half | 51 (41.8) | 104 (55.3) | |
| Risk Group | 0.001 | ||
| A | 21 (17.2) | 76 (40.4) | |
| B | 48 (39.3) | 38 (20.2) | |
| C | 33 (27) | 59 (31.4) | |
| D | 6 (4.9) | 0 (0) | |
| E | 14 (11.5) | 15 (8) |
SD = Standard Deviation
ICU = Intensive care unit